NPI Details
Daniil Niyazov, MD is an internal medicine in Delmar, NY with 11 years of experience. The provider is a physician who provides long-term, comprehensive care in the office and the hospital, managing both common and complex illness of adolescents, adults and the elderly. Internists are trained in the diagnosis and treatment of cancer, infections and diseases affecting the heart, blood, kidneys, joints and digestive, respiratory and vascular systems. They are also trained in the essentials of primary care internal medicine, which incorporates an understanding of disease prevention, wellness, substance abuse, mental health and effective treatment of common problems of the eyes, ears, skin, nervous system and reproductive organs. Daniil Niyazov, MD NPI is 1225457039. The provider is registered as an individual entity type.
The NPPES NPI record indicates the provider is a male.
The provider's business location address is:
250 DELAWARE AVE STE 100
DELMAR, NY
ZIP 12054-402
Phone: (518) 439-8077
Fax: (518) 439-8070
The NPI 1225457039 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.
The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.
- Insertion of needle into vein for collection of blood sample (HCPCS:36415)
- Blood test, comprehensive group of blood chemicals (HCPCS:80053)
- Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
- Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
- Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
- Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
- Blood test, lipids (cholesterol and triglycerides) (HCPCS:80061)
- Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report (HCPCS:93000)
- Vitamin d-3 level (HCPCS:82306)
- Blood test, clotting time (HCPCS:85610)
- Hemoglobin a1c level (HCPCS:83036)
- Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
- Ferritin (blood protein) level (HCPCS:82728)
- Iron level (HCPCS:83540)
- Iron binding capacity (HCPCS:83550)
- Administration of influenza virus vaccine (HCPCS:G0008)
- Folic acid level, serum (HCPCS:82746)
- Influenza vaccine split virus, preservative free (HCPCS:90662)
- Telephone medical discussion with physician, 5-10 minutes (HCPCS:99441)
- Analysis for antibody borrelia burgdorferi (lyme disease bacteria) (HCPCS:86618)
- Automated urinalysis test (HCPCS:81003)
- Blood test, basic group of blood chemicals (calcium, total) (HCPCS:80048)
- Bacterial colony count, urine (HCPCS:87086)
- Urine microalbumin (protein) level (HCPCS:82043)
- Telephone medical discussion with physician, 11-20 minutes (HCPCS:99442)
- Administration of pneumococcal vaccine (HCPCS:G0009)
- Magnesium level (HCPCS:83735)
- Creatinine level to test for kidney function or muscle injury (HCPCS:82570)
- Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use (HCPCS:90677)
- Transitional care management services for problem of moderate complexity (HCPCS:99495)
- Red blood cell sedimentation rate, to detect inflammation, automated (HCPCS:85652)
- Measurement c-reactive protein for detection of infection or inflammation (HCPCS:86140)
- Prostate cancer screening; prostate specific antigen test (psa) (HCPCS:G0103)
- Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit (HCPCS:G0438)
- Psa (prostate specific antigen) measurement, total (HCPCS:84153)
- Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r (HCPCS:U0003)
- Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within (HCPCS:U0005)
The enumeration date for this NPI number is 4/9/2014 and was last updated on 7/21/2022.
Taxonomy Codes
The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:
| No. |
Taxonomy Code |
Taxonomy Clasification |
Taxonomy Specialization |
License Number |
License State |
Primary |
| 1 | 390200000X | Student in an Organized Health Care Education/Training Program | | 63498 | NEW YORK | No |
| 2 | 207R00000X | Internal Medicine | | 288680 | NEW YORK | Yes |
Other Identifiers
The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.
| No. |
Other Provider Identifier |
Other Provider Identifier Type |
Other Provider Identifier State |
Other Provider Identifier Issuer |
| 1 | 04823314 | MEDICAID | NEW YORK | |
